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Coronary Atherosclerosis Imaging by
Coronary CT Angiography
Current Status, Correlation With Intravascular Interrogation and Meta-Analysis
Szilard Voros, MD,* Sarah Rinehart, MD,* Zhen Qian, PHD,* Parag Joshi, MD,*
Gustavo Vazquez, MD,* Collin Fischer, MD,† Pallavi Belur, DO,†
Edward Hulten, MD, MPH,† Todd C. Villines, MD†
Atlanta, Georgia; and Washington, DC
Coronary computed tomography angiography (CTA) allows coronary artery visualization and the detec-
tion of coronary stenoses. In addition; it has been suggested as a novel, noninvasivemodality for coronary
atherosclerotic plaque detection, characterization, and quantification. Emerging data show that coronary
CTA–based semiquantitative plaque characterization and quantification are sufficiently reproducible for
clinical purposes, and fully quantitative approaches may be appropriate for use in clinical trials. Further-
more, several lines of investigation have validated plaque imaging by coronary CTA against other imaging
modalities such as intravascular ultrasound/“virtual histology” and optical coherence tomography, and
there are emerging data using biochemical modalities such as near-infrared spectroscopy. Finally,
clinical validation in patients with acute coronary syndrome and in the outpatient setting has shown
incremental value of CTA-based plaque characterization for the prediction of major cardiovascular
events. With recent developments in image acquisition and reconstruction technologies, coronary
CTA can be performed with relatively low radiation exposure. With further technological innovation
and clinical research, coronary CTA may become an important tool in the quest to identify vulnerable
plaques and the at-risk patient. (J Am Coll Cardiol Img 2011;4:537–48) © 2011 by the American
College of Cardiology FoundationWal
o In
d thMolecular and cellular events leading to ath-
erosclerosis, such as lipoprotein deposition, in-
flammation, smooth muscle cell proliferation,
apoptosis, necrosis, calcification, and fibrosis,
cause specific compositional and geometric
changes in coronary vessels (1). Some of these
changes, such as increased plaque volume, pos-
itive remodeling, lipoprotein deposition in the
form of noncalcified plaques, and calcification,
can be detected by contrast-enhanced coronary
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this article, we review qualitative and quantita-
tive plaque characterization and serial plaque
imaging with coronary CTA.
Coronary Plaque Imaging by Coronary CTA
Coronary CTA is typically performed on mul-
tidetector CT systems after the injection of
iodine contrast media for opacification of the
ter Reed Medical Center, Washington, DC. Dr.
c., Vital Images, Siemens Medical Solutions, and
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538lumen. Current multidetector CT systems have an
isotropic spatial resolution of approximately 400 to
600 m and temporal resolution of approximately
3 to 175 ms (2). Coronary arterial plaques are
ypically reviewed in either axial or multiplanar
eformatted planes, as well as in curved multiplanar
eformats (Fig. 1).
To some degree, plaques can be classified based
n their typical visual appearance. The contrast-
nhanced lumen can be easily identified as areas of
igh attenuation (approximately 200 to 500
ounsfield units [HU]). Any discernible structure
utside the lumen that is either calcified or has
ttenuation value less than the lumen is considered
o be part of the plaque. Based on the relative
mount of calcified and noncalcified components,
laques are usually classified into 1 of 3 categories:
oncalcified plaque, calcified plaque, or partially
alcified plaque (sometimes referred to as “mixed
laque”) (Fig. 1).
Qualitative Plaque Characterization
A simple, qualitative plaque characteriza-
tion scheme has been used for clinical
reporting of plaque types on contrast-
enhanced CTA (3). Each of the 17 coro-
nary segments are visually assessed and
classified on the basis on stenosis severity,
and each plaque is classified as calcified,
noncalcified, or partially calcified. The re-
producibility of this qualitative assessment
(Fig. 1) has been shown to be good with
both intraobserver and interobserver
agreement in excess of 0.88 (Table 1) (4,5).
The accuracy of this qualitative plaque character-
zation approach has been evaluated by Pundziute
t al. (6), who showed that the 3 different types of
laque had significantly different composition as
ssessed by intravascular ultrasound (IVUS) with
adiofrequency backscatter analysis (IVUS/“virtual
istology” [VH]). Importantly, they showed that
2% of partially calcified plaques in CT was char-
cterized as thin-cap fibroatheroma (TCFA) by
VUS/VH.
Quantitative Plaque Characterization
Reproducibility. Hoffmann et al. (7) published re-
producibility data for total plaque volume in 20
patients, showing that limits of agreement were
approximately 60% for small volumes (10 mm3) and
ome
hy
y”
ma8% for larger volumes (100 mm3). Cheng et al. (8) sxamined intraobserver, interobserver, and inter-
can variability in 89 proximal segments in 30
atients, using manual delineation of calcified and
oncalcified components. They showed that al-
hough there was strong correlation between ob-
ervers and mean differences were small, limits of
greement were wide (20% to 269%) for the mea-
urement of total and noncalcified plaque volumes.
everal other groups have also shown good repro-
ucibility, mostly for noncalcified lesions (9–12)
nd with best reproducibility in the left anterior
escending artery (13).
Our group recently published that using a standard-
zed approach, interobserver agreement was high (Fig.
) (5). Mean differences for directly measured geo-
etric parameters such as the minimum luminal
iameter and minimum luminal area were small
0.45% and 0.43%, respectively), and limits of agree-
ent were also narrow (11.8% and18.5%, respec-
ively). For compositional parameters, mean differ-
nces were small (1%) and limits of agreement were
lso narrow (4.8% to 32.8%) (14).
Accuracy. VALIDATIONOF CORONARY CTA AGAINST
VUS Several recent studies evaluated the accuracy of
T-derived geometric parameters of coronary athero-
clerotic plaque against IVUS. This included measures
f stenosis severity (minimum luminal diameter; min-
mum luminal area and percent stenosis; and measures
o quantify plaque burden, such as plaque area, plaque
olume, and percent atheroma volume). Our group
ecently showed that on a segmental basis, CT under-
stimated minimum luminal diameter by 21% and
verestimated diameter stenosis by 39%. Minimum
uminal area was overestimated on CT by 27%, but
rea stenosis was only underestimated by 5% (14).
META-ANALYSIS OF CORONARY CTA AGAINST
IVUS. We conducted a meta-analysis to assess the
ccuracy of coronary CTA against IVUS regarding
oronary vessel and plaque sizes, as well as the accu-
acy (sensitivity and specificity) of CT to detect any
laque compared with IVUS. From a search of MED-
INE, EMBASE, and published abstracts of the Amer-
can College of Cardiology and American Heart Asso-
iation, we searched among human studies published
rom 1998 to 2010 without language restrictions. Using
he search terms and MeSH keywords for IVUS,
ntravascular ultrasound, digital subtraction angiogra-
hy, VH, CTA, coronary CTA, cardiac CT, com-
uted tomography, multislice CT, multidetector CT,
SCT, MDCT, dual source CT, DSCT, and spiral
T, we identified 3,699 relevant abstracts through
atabase searching and 10 abstracts through otherA B B R E V I A T I O N S
A N D A C R O N YM S
ACS acute coronary syndr
CTA computed tomograp
angiography
IVUS/VH intravascular
ultrasound/“virtual histolog
NIRS near-infrared
spectroscopy
OCT optical coherence
tomographyources. After full-text review of 95 qualifying articles,
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539we excluded 61 and included 33 studies that were
published between 2001 and 2010 and included a total
of 946 patients (mean age 59 years; 76% male).
We used the meta-analysis command (metan) for
Stata (version 11.0 special edition, StataCorp, College
Station, Texas) to determine the weighted mean
difference (WMD) for vessel lumen area, plaque area,
percent area stenosis, and plaque volume. A fixed-
effects model was used except in the case of plaque
volume (random effects). The Stata module for meta-
analysis of diagnostic studies (midas) was used with a
bivariate model to pool sensitivity, specificity, and
receiver operating characteristic curves. Heterogeneity
was assessed using I2 (15).
Twenty studies were identified that assessed ac-
uracy of coronary CTA to detect plaques, and 22
tudies were identified that compared vessel and
laque dimensions (Table 2).
Coronary CTA had excellent diagnostic accuracy
or the detection of coronary plaques against IVUS
s reference standard, with an area under the curve
or receiver operating characteristic analysis of 0.94
95% confidence intervals [CI]: 0.92 to 0.96), with
sensitivity of 0.90 (95% CI: 0.83 to 0.94) and a
Figure 1. Different Types and Visualization of Coronary Plaques
Typical visualization of coronary plaques is illustrated in axial (A, D,
(C, F, and I) views. The 3 main types of coronary plaques are showpecificity of 0.92 (95% CI: 0.90 to 0.93) (Fig. 3).he data were heterogeneous for sensitivity (I2 
82%) (15), which was in part explained by scanner
type: sensitivity for the 16-slice scanner was 0.84
(95% CI: 0.80 to 0.88), whereas 64-slice sensitivity
was 0.94 (95% CI: 0.83 to 0.98). For quantitative
analysis, CT slightly overestimated lumen area by
0.46 mm2 (95% CI: 0.14 to 0.79), or by 6.7% (p 
0.005) (Fig. 4A). Plaque area and volume were
similar between CT and IVUS (plaque area mean
difference 0.09 mm2, 95% CI: 1.00 to 1.18 mm2,
 0.88; plaque volume mean difference 5.30
m3, 95% CI: 3.01 to 13.60 mm3, p  0.21)
Figs. 4B and 4C, respectively). There was statisti-
ally significant heterogeneity (I2  58%, p 
0.008) due to an outlier for plaque volume measure-
Computed Tomography
G), curved planar reformatted (B, E, and H), and cross-sectional
oncalciﬁed plaque, partially calciﬁed plaque, and calciﬁed plaques.
Table 1. Intra-Rater and Inter-Rater Reliability for Qualitative P
Assessment (Weighted Kappa)
Stenosis Plaque
Intra-Rater Inter-Rater Intra-Rater In
Rinehart et al. (5) 0.96 0.90 0.96
Lehman et al. (4) 0.95 0.93 N/Aby
andlaque
ter-Rater
0.88
N/AN/A  not applicable.
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540ments (14), a study that included patients with
advanced coronary artery disease. Removal of this
outlier removed all statistical heterogeneity (I2 
0%) but did not significantly influence the effect size
of the WMD, which, by exclusion of the outlier,
changed to 2.15 mm3 (95% CI: 6.29 to 10.60,
 0.62). Finally, percent area stenosis was similar
etween CT and IVUS (WMD 1.81%, 95% CI:
4.10 to 0.49, p  0.12) (Fig. 4D). This meta-
nalysis confirmed that coronary CTA may slightly
verestimate luminal area, presumably because of
artial volume effects that lead to overestimation of
Figure 2. Inter-Rater Reliability for Calciﬁed, Noncalciﬁed, Low-
Plaque segmentation between different observers is shown in the i
volume (A) and percentage (B) conﬁrm no signiﬁcant difference be
excellent interobserver reproducibility. Blue  high-density noncalc
high density; LD  low density; red  low-density NCP.he size of very bright structures (such as the fontrast-enhanced lumen), whereas plaque area,
olume, and area stenosis measurements are similar
etween CT and IVUS (Fig. 5).
For plaque characterization, it has been shown
hat CT-derived attenuation values are different
n calcified and noncalcified plaques (Table 3).
urthermore, Choi et al. (16) demonstrated that
laques with more than 10% “necrotic core” based
n IVUS/VH had significantly lower attenuation
alues, compared with plaques with less than 10%
ecrotic core (41.3  26.4 HU vs. 93.1  37.5 HU).
A few studies have evaluated the accuracy of CT
sity Noncalciﬁed, and High-Density Noncalciﬁed Plaques
e (observer 1: A; observer 2: B). (C) Bland-Altman plots for the
en observers, with very narrow limits of agreement, conﬁrming
plaque (NCP); CAP  calciﬁed plaque; green  lumen; HD Den
mag
twe
iﬁedor quantification of the percentage of calcified and
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541noncalcified plaques, using pre-defined attenuation
values for segmentation on CTA and using
IVUS/VH as reference standard. Otsuka et al. (17)
showed that 64-slice CTA slightly underestimated
noncalcified plaque volume (by approximately 17%)
and overestimated mixed/calcified plaque volume
(by approximately 3%). Using dual-source 64-slice
technology, Brodoefel et al. (18) showed that auto-
mated HU-based thresholding overestimated the
percentage of calcified and lipid-rich components (by
2.2% and 3.7%, respectively) and underestimated fatty
plaque components by 5.6%. Subsequently, they
showed that dual-source 64-slice CT with commercial
post-processing software had poor accuracy for the
determination of plaque components (19).
Conversely, our group showed significant correla-
tion between 64-slice CT and IVUS/VH for the
determination of plaque composition (14). On a slice
by slice basis, lumen, vessel, noncalcified, and calcified
plaque areas were overestimated by 22%, 19%, 44%,
and 88%, respectively. This study demonstrated that
Table 2. Characteristics of Individual Studies That Assessed Cor
First Author (Ref. #)* Year n Vessels/Plaques, n
Achenbach 2004 22 83 segments
Brodefel 2009 12 20 noncalciﬁed plaques
Brodoefel 2008 13 20 plaques
Brodoefel 2009 14 22 plaques
Bruining 2007 48 48 segments
Caussin 2006 36 50 plaques
Caussin 2005 51 51 plaques
Dragu 2008 20 20 vessels (all left main)
Hara 2007 33 56 plaques
Hur 2009 39 61 segments
Iriart 2007 20 169 segments, 84 plaque
Leber 2006 19 36 vessels,
365 cross-sections
Leber 2005 18 32 vessels, 46 plaques
Moselewski 2004 26 26 vessels,
65 cross-sections
Okabe 2008 51 69 plaques
Otsuka 2008 47 100 vessels, 76 plaques
Petranovic 2009 11 17 segments
Sato 2008 30 32 plaques
Schepis 2010 70 100 plaques
Sun 2008 26 40 vessels, 247 segments
Ugolini 2009 30 376 segments
Voros 2011 50 50 patients
Ye 2007 12 31 vessels, 68 segments
Twenty studies were identiﬁed that assessed the accuracy of coronary comput
plaque dimensions. *Table references are available in the online appendix. †Ag
thickness (mm).
DS  dual-source CT; N/R  not reported.low-density noncalcified plaques, the presumed lipid- irich plaques on CT, correlated best with the sum of
necrotic core plus fibro-fatty tissue by IVUS/VH (14).
VALIDATIONOF CORONARY CTA AGAINSTOCT AND
NEAR-INFRARED SPECTROSCOPY. Kashiwagi et al.
20) compared CT findings with those from optical
oherence tomography (OCT). In 105 patients, cor-
nary lesions were classified as TCFA or non-TCFA
y OCT (20). Although outer vessel area, lumen area,
nd plaque burden were similar for both plaque types,
emodeling index was significantly higher in TCFAs
1.14  0.15 vs. 1.02  0.10; p  0.0001), and the
proportion of positive remodeling was significantly
higher (76% vs. 31%; p  0.001). Furthermore, CT
demonstrated significantly lower attenuation values in
TCFAs (35.1  32.3 HU vs. 62.0  33.6 HU; p 
.001). Finally, “ring-like” enhancement, or contrast
ccumulation in the periphery of the plaque but not in
he necrotic core, were more common in TCFAs
44% vs. 4%; p  0.0001).
Although IVUS and OCT represent morpholog-
cal validation, near-infrared spectroscopy (NIRS)
ry Artery Vessel Parameters
Men, % Mean Age, yrs† CT Parameters‡
64 58 16–420–0.75 N/R, 80 ml a
92 65 7 64 DS–330–0.6 Iomeron 400
92 65 7 64 DS–330–0.6 Iomeron 400
79 66 7 64 DS–330–0.6 Iomeron 400
79 59 10 16–420–0.75 Visipaque 32
N/R 63 10 64–330–0.6 N/R
N/R 62 13 16–420–0.75 N/R
85 53 15 16–420–0.75 Ultravist, 12
82 65 9 16–400 to 500–0.5 Iopamiron 3
72 59 64–330–0.6 Iopamiro 37
85 53 12 16–420–0.75 Iomeron 400
90 59 9 64–330–0.6 Solutrast 30
N/R 64 10 64–330–0.6 Solutrast 30
65 62 16–420–0.75 N/R, 80 ml a
37 64 10 64–420–0.6 Isovue 370,
83 53 11 64–330–0.6 Iomeron 400
N/R N/R 64–330–0.6 N/R, 5 ml/s
73 67 11 64–500–0.5 Iopamidol 3
80 57 11 64DS–330–0.6 Iomeprol 35
65 56 64–400–0.5 N/R, 70–85 m
77 59 64–350–0.625 Iodixanol 32
58 58.7 7 64–330–0.6 Visipaque 32
N/R N/R 64–330–0.6 N/R
omography (CT) angiography to detect plaques, and 22 studies were identiﬁed t
reported as mean  SD. ‡CT parameters are reported as number of slices–gantrona
Contrast
t 4 ml/s
, 80 ml at 5 ml/s
, 80 ml at 5 ml/s
, 80 ml at 5 ml/s
0, 120 ml at 4 ml/s
0 ml at 4 ml/s
70, 100 ml at 4 ml/s
0, 60–90 ml at 5 ml/s
s , 80 ml at 4 ml/s
0, 80 ml at 5 ml/s
0, 80 ml at 5 ml/s
t 4 ml/s
80 ml at 5 ml/s
, 100 ml at 4 ml/s
70, 60 ml at 4 ml/s
0, 60–90 ml at 6 ml/s
l at 4 ml/s
0, 85 ml at 5 ml/s
0, 80 ml at 3–5 ml/s
ed t hat compared vessel and
e is y rotation time (ms)–slicedentifies cholesterol based on the infrared light
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542Figure 3. Pooled Sensitivity and Speciﬁcity for Coronary CTA Versus IVUS
Pooled sensitivity and speciﬁcity for coronary computed tomography angiography (CTA) to detect any coronary plaques as compared with
intravascular ultrasound (IVUS). The corresponding receiver operating characteristic (ROC) curve and area under the curve (AUC) are shown on
2 2the right. There was signiﬁcant heterogeneity for sensitivity (SENS; I  82%) but not speciﬁcity (SPEC; I  44%). CI  conﬁdence interval.IVUS Larger
Author Year n                 WMD Vessel Lumen Cross-Sectional Area,
   mm2 (95% CI)
CCTA Larger (mm2)
1050-5-10
Caussin 2005 51 0.40 (-0.61, 1.41)
Dragu 2008 20 0.80 (-2.83, 4.43)
Hara 2007 33 0.70 (-2.58, 3.98)
Iriat 2007 20 -0.12 (-2.49, 2.25)
Moselewski 2004 26 0.70 (-3.73, 5.13)
Subtotal, p = 0.37   0.39 (-0.47, 1.24)
16 Slice Studies
Caussin 2006 36 -0.10 (-1.37, 1.17)
Hur 2009 39 0.20 (-0.77, 1.17)
Leber 2005 18 1.00 (-2.14, 4.14)
Okabe 2008 51 1.16 (0.06, 2.26)
Petranovic 2009 11 1.20 (-3.79, 6.19)
Sato 2008 30 0.27 (-0.24, 0.78)
Sun 2008 26 -0.51 (-2.24, 1.22)
Voros 2010 50 1.40 (0.50, 2.30)
Subtotal, p = 0.008   0.48 (0.12, 0.83)
Overall, p = 0.005   0.46 (0.14, 0.79)
64 Slice Studies
IVUS Larger CCTA Larger (mm2)
1050-5-10
Author Year n WMD Plaque Area,
   mm2 (95% CI)
Moselewski 2004 26 1.00 (-1.20, 3.20)
Subtotal, p = 0.37   1.00 (-1.20, 3.20)
16 Slice Studies
Hur 2009 39 -1.70 (-3.55, 0.15)
Leber 2005 18 -0.80 (-3.74, 2.14)
Petranovic 2009 11 1.60 (-1.72, 4.92)
Ye 2007 12 2.29 (-0.43, 5.01)
Subtotal, p = 0.74   -0.21 (-1.47, 1.04)
Overall, p = 0.88   0.09 (-1.00, 1.18)
64 Slice Studies
0
Achenbach 2004 22 -19.00 (-48.03, 10.03)
Bruining 2007 48 33.00 (-10.17, 76.17)
Subtotal, p = 0.82   -2.81 (-26.90, 21.28)
Brodoefel 2009 12 -7.10 (-24.60, 10.40)
Brodoefel 2008 13 10.60 (-8.20, 29.40)
Brodoefel 2009 14 7.70 (-15.27, 30.67)
Leber 2006 19 -3.10 (-58.25, 52.05)
Otsuka 2008 47 -2.00 (-33.94, 29.94)
Petranovic 2009 11 30.00 (-12.28, 72.28)
Schepis 2010 70 -1.00 (-24.05, 22.05)
Ugolini 2009 30 3.00 (-39.27, 45.27)
Voros 2010 50 96.20 (50.80, 141.60)
Subtotal, p = 0.16   6.39 (-2.45, 15.23)
Overall, p = 0.21   5.30 (-3.01, 13.60)
Author Year n WMD Plaque Volume,
   mm3 (95% CI)
IVUS Larger CCTA Larger (mm3)
200100-100-200
16 Slice Studies
64 Slice Studies
0
Dragu 2008 20 0.00 (-11.07, 11.07)
Hara 2007 33 1.40 (-7.67, 10.47)
Iriat 2007 20 -11.25 (-20.22, -2.28)
Moselewski 2004 26 1.00 (-8.49, 10.49)
Subtotal, p = 0.30   -2.55 (-7.33, 2.23)
Brodoefel 2009 14 2.00 (-9.49, 13.49)
Hur 2009 39 -4.30 (-8.88, 0.28)
Leber 2005 18 -9.30 (-21.62, 3.02)
Petranovic 2009 11 3.50 (-12.10, 19.10)
Sato 2008 30 -0.20 (-4.96, 4.56)
Sun 2008 26 4.77 (-3.95, 13.49)
Voros 2010 50 -2.10 (-8.67, 4.47)
Subtotal, p = 0.24   -1.58 (-4.19, 1.03)
Overall, p = 0.12   -1.81 (-4.10, 0.49)
Author Year n WMD % Area Stenosis,
   % (95% CI)
IVUS Larger CCTA Larger (%)
302010-10-20-30
16 Slice Studies
64 Slice Studies
A C
 
B D
 
Figure 4. Coronary CTA Versus IVUS to Compare Vessel Lumen Area, Plaque Volume, Plaque Area, and Percent Area Stenosis
Weighted mean difference (WMD) for coronary CTA and IVUS comparing (A) vessel lumen cross-sectional area, (B) plaque area, (C)
plaque volume, and (D) percent area stenosis. There was no signiﬁcant heterogeneity except for plaque volume, which was moderately
heterogeneous because of an outlier (see text). Abbreviations as in Figure 3.
US/
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543absorption spectrum. In a preliminary, prospective
study, we evaluated coronary arterial segments by
CT, IVUS/VH, and NIRS. After spatial coregis-
Figure 5. Spatially Coregistered Coronary CTA and IVUS/VH
Spatially coregistered long-axis views of a coronary plaque are show
Corresponding cross-sectional views are shown by (B) CT and (D) IV
Table 3. CT-Derived Attenuation Values in Calciﬁed, Fibrous, an
First Author (Ref. #)* Year
Ex vivo studies
Becker 2003
Schroeder 2004
Ferencik 2006
Xiao 2007
Xiao 2007
Galonska 2008
In vivo studies (using IVUS as reference standard)
Schroeder 2001
Carrascosa 2003
Caussin 2004
Leber 2004
Carrascosa 2006
Sakakura 2006
Iriart 2007
Motoyama 2007
Pohle 2007
Kitagawa 2007
Brodoefel 2008
Sun 2008
Hur 2009
Kim 2009
Mean  SD in Hounsﬁeld units. *Table references are available in the onlin
tomography (CT).
IVUS  intravascular ultrasound.tration of all 3 modalities, we showed good corre-
lation between the location of noncalcified plaques
in CT and IVUS/VH and cholesterol on NIRS
y (A) CT, (C) IVUS/“virtual histology” (VH), and (E) grey-scale IVUS.
VH. Abbreviations as in Figures 3 and 4.
ipid-Rich Plaques
anner Calciﬁed Fibrous Lipid Rich
slice N/A 104 28 47 9
slice 715 328 70 21 42 22
-slice 135 199 101 21 29 43
-slice 429 94 106 17 53 12
-slice 435 87 110 19 51 13
-slice 1,089† 67† 44†
slice 419 194 91 21 14 26
slice 449.1 221.4 148.6 36.6 75.7 44.3
-slice Not reported 63.8 18.9 12 38
-slice 391 156 91 22 49 22
slice 383.3 186.1 116.3 35.7 71.5 32.1
-slice 721 231 131 21 50.6 14.8
-slice 561 216 94 44 38 33
-slice 516 198 78 21 11 12
-slice Not reported 121 34 58 43
-slice Not reported 67 21 18 17
-slice‡ (437) (70–158) (10–69)
-slice 772 251 90 27 79 34
-slice 392 155 82 17 54 13
-slice Not reported 98.6 34.9 52.9 24.6
pendix. †Reported as median value; SD not given. ‡Dual-source computedn bd L
Sc
4-
4-
16
16
64
16
4-
4-
16
16
4-
16
16
16
16
64
64
64
64
64
e ap
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544(Fig. 6). Plaque burden by CTA correlated well
with cholesterol deposition by NIRS (Fig. 6G).
Similarly, noncalcified plaques, as well as low- and
high-density noncalcified plaques, also correlated
well with cholesterol on NIRS (Figs. 6H, 6I,
Figure 6. NIRS, CTA, and IVUS/VH in Coronary Plaques
Spatially coregistered (A) near-infrared spectroscopy (NIRS), (B) CTA
was created from the NIRS image; the intensity of the yellow color
simulated block chemogram from (E) coronary CTA and (F) IVUS/VH
tial agreement for the presence of a noncalciﬁed plaque and chole
NIRS, there was signiﬁcant, linear correlation between the probabili
noncalciﬁed plaque (r  0.52), (I) low-density noncalciﬁed plaque (r
ations as in Figures 3 and 4.and 6J).Predictive Value of Plaque Characterization by
Coronary CTA
Plaque characteristics in acute coronary syndrome.
Early CT-based retrospective studies indicated that
d (C) IVUS/VH of a coronary plaque. (D) The block chemogram
roportional to the probability of the presence of cholesterol. The
ects the presence of a noncalciﬁed plaque and displays the spa-
l between modalities. Based on spatial coregistration of CT and
f cholesterol by NIRS and CTA for (G) plaque burden (r  0.5), (H)
0.49), and (J) high-density noncalciﬁed plaque (r  0.51). Abbrevi-, an
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545syndrome (ACS) have larger vessel areas (21.2 
7.0 mm2 vs. 11.8  5.7 mm2), more positive
emodeling (remodeling index 1.4  0.3 vs. 1.0 
.4), and less overall calcification, compared with
onculprit lesions (21–24). Several small studies
onsistently showed that culprit lesions in ACS had
higher proportion of positive remodeling (22–24)
nd higher remodeling index (21). In addition,
ulprit lesions had a higher proportion of noncalci-
ed and partially calcified components (6,23,25–27),
nd they had lower overall attenuation values
25,26,28). Huang et al. (29) compared plaque char-
cteristics in patients with ACS with ST-segment
levation versus those without ST-segment elevation
nd showed that the presence of ST-segment eleva-
ion was associated with greater plaque burden, higher
emodeling index, and lower plaque attenuation
alues.
Motoyama et al. (30) demonstrated in a large,
etrospective study that culprit lesions of ACS had
higher proportion of positive remodeling (87% vs.
2%; p  0.0001), more frequently had compo-
ents with attenuation values below 30 HU (79%
s. 9%; p  0.0001), and typically had “spotty”
calcification. They later confirmed in a prospective
trial that lesions that would cause ACS during
further follow-up had larger remodeling index, total
plaque volume, and low-attenuation plaque volume
at baseline (31). Interestingly, Harigaya et al. (32)
showed that in patients who presented with ACS
and underwent percutaneous coronary intervention
of the culprit lesion, low attenuation plaques were
Figure 7. Progression of Atherosclerosis and Relationship Amon
In a normal vessel, approximately 65% of the volume is occupied b
eling, there is an increase in atheroma volume and percent atherom
positive remodeling is characterized by further increase in atherom
lumen volume and atheroma volume decrease, whereas PAV continmore frequent in patients who subsequently hadno-reflow phenomenon, compared with those pa-
tients who did not (82% vs. 52%).
Plaque characteristics and clinical outcomes. Pundz-
ute et al. (33) were the first to report on the
redictive value of coronary CTA for cardiovascular
vents, demonstrating that any plaque as well as
artially calcified plaques were independent predic-
ors of outcome. Min et al. (34) followed with a
arger validation cohort, demonstrating that the
resence of plaques in at least 5 coronary artery
egments was associated with all-cause mortality.
he degree of luminal stenosis, plaque type, and the
umber of involved segments have been combined
nto segment stenosis score and segment involve-
ent score, with risk-adjusted hazard ratios of 1.52
95% CI: 1.09 to 2.14, p 0.01) and 1.16 (95% CI:
.05 to 1.28, p  0.004), respectively.
Ostrom et al. (35) published a series of 2,538
onsecutive patients followed over 78 months and
howed that risk-adjusted hazard ratios were
.7-, 1.8-, 2.3-, and 2.6-fold for 3-vessel nonob-
tructive and 1-, 2-, and 3-vessel obstructive
oronary plaques, respectively, as detected by
ontrast-enhanced electron beam tomography.
imilarly, Hadamitzky et al. (36) showed that the
resence of stenoses with 50% diameter reduc-
tion had an odds ratio of 16.1 for all cardiac
events. Finally, a recent, important study showed
that CT-derived plaque type had important pre-
dictive value, demonstrating that mortality incre-
mentally increased from calcified plaque (1.4%)
to partially calcified plaque (3.3%) to noncalcified
umen Volume, Atheroma Volume, and PAV
e lumen and 35% by the vessel wall. During early positive remod-
olume (PAV), with the preservation of the lumen volume. Late
lume and PAV, with luminal compromise. In the ﬁnal stages,
to increase, making PAV one of the best markers of progression.g L
y th
a v
a voplaque (9.6%) (37).
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546Serial Imaging:
Changes in Plaque Over Time and Effect of Therapy
Different quantitative measurements can be moni-
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Figure 8. Quantitative Measurement of Coronary Plaque Progre
Representative cross-sectional view of an atherosclerotic plaque is shown
Quantitative measurements demonstrated a signiﬁcant decrease in minim
in percent diameter stenosis (DS) (E). Also, a signiﬁcant increase in the per
low-density and high-density noncalciﬁed plaque (F) were found. Y1  yetored over time; of these , percent atheroma volumemay be the best measure of progression or regres-
sion (Fig. 7). Schmid et al. (38) measured the
volume of noncalcified plaques in the left main and
proximal left anterior descending artery in 50 pa-
08
02
7.7±2.8
LDNCP Y1
63.9±15.6
p=0.04
%HDNCP
0
20
10
50
60
40
30
70
60.5±17.2
%HDNCP Y1
4.6±2.4
MLA Y1
45.3±16.2
p=0.03
%DS
0
20
10
40
30
50
60
50.5±18.7
%DS Y1
Means (error bars: 95% CI for mean)5% CI for mean)
Means (error bars: 95% CI for mean)5% CI for mean)
n by Coronary CTA at Baseline and 12 Months Later
and C) baseline and (B and D) 12 months later in the same slice.
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age of calciﬁed plaque and signiﬁcant decrease in the percentage of
; other abbreviations as in Figures 3 and 4.=0.0
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547found a significant increase in plaque volume (from
91  81 mm3 to 115  110 mm3), with an
nnualized increase of 22%. Burgsthaler et al. (39)
valuated 28 patients assigned to lipid-lowering
herapy at baseline and 18 months later and showed
significant decrease in total plaque volume (149
08 mm3 to 128  0.075 mm3) and a nonsignifi-
cant decrease in noncalcified plaque volume (42 
29 mm3 to 30  14 mm3). Lehman et al. (4)
published significant progression of atherosclerosis
in 69 patients from baseline to 2-year follow-up, as
evidenced by a significant increase in the number of
cross-sectional slices with any plaque (16.5  25.3
vs. 18.6  25.5; p  0.01) and noncalcified plaque
(3.1  5.8 vs. 4.4  7.0; p  0.04). Similar results
were obtained by Inoue et al. (40).
Our group evaluated quantitative changes from
baseline to follow-up 12 months later, showing
significant decrease in lumen and increase of diam-
eter stenosis over time (Fig. 8). Furthermore, there
was significant increase in the percentage of calci-plaque evaluation between multislice
1
2008;24:735–42.Summary, Conclusions, and Future Directions
Accurate detection of coronary atherosclerotic
plaques by CT remains difficult but can be per-
formed with modern equipment, after careful pa-
tient selection and with sufficient expertise. At-
tempts at plaque quantification and characterization
have been successful, but further refinements re-
garding reproducibility, accuracy, and ability to
predict future events are required. With further
improvements in hardware and software, contrast-
enhanced coronary CTA may become part of the
armamentarium in the quest for the detection of the
“vulnerable plaque” and the “vulnerable patient” so
that appropriate preventive measures can be insti-
tuted in a targeted fashion, at least partially based
on the findings of coronary CTA.
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